Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1520 (LINC01520) is a member of the long non-coding RNAs (lncRNAs), specifically classified as an intergenic lncRNA, meaning it is located between protein-coding genes in the genome and does not code for proteins itself[1][3]. LINC01520 is catalogued in major human gene databases, but its specific molecular and cellular functions, interacting partners, and roles in human disease are currently poorly characterized. There is no evidence in the literature supporting its use as a therapeutic target, biomarker, or its interaction with any approved or investigational drug. Long intergenic non-coding RNAs such as LINC01520 generally participate in the regulation of gene expression at the transcriptional and post-transcriptional level[5], but the detailed biological functions and disease roles of LINC01520 have not yet been specifically elucidated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1520 (LINC01520).